Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NBTY Vows Retail Turnaround In Three Months, Touts Ester-C Brand Appeal

This article was originally published in The Tan Sheet

Executive Summary

Nutritional supplement manufacturer and marketer NBTY intends to complete the overhaul of its retail operations in the next 90 days and "to make the chain profitable and to grow it again," President and CFO Harvey Kamil said Nov. 5

You may also be interested in...



NBTY’s Ester-C Plans Under Wraps But Shining Through; Firms Strategize

NOW Foods is developing a "replacement Ester-C product" with the goal of selling it as a branded ingredient to other firms, National Sales Manager Dan Richard told "The Tan Sheet.

FDA On Lookout For “Shenanigans” In Nutritionals – Consultant

More FDA enforcement action is focusing on regulatory compliance by nutritional supplement firms in part because there is "plenty of room for shenanigans" in marketing the products, according to John Avellanet, a compliance consultant

FDA On Lookout For “Shenanigans” In Nutritionals – Consultant

More FDA enforcement action is focusing on regulatory compliance by nutritional supplement firms in part because there is "plenty of room for shenanigans" in marketing the products, according to John Avellanet, a compliance consultant

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101093

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel